Drug Maker Teva to Pay Over $500 Million in New York Drug Case Settlementnews2022-11-03T21:11:11+00:00November 3rd, 2022|The New York Times|
F.D.A. Confirms Widespread Shortages of Adderallnews2022-10-13T18:04:42+00:00October 13th, 2022|The New York Times|
Allergan Reaches Tentative $2.37 Billion Deal to Settle Opioid Suitsnews2022-07-29T17:08:24+00:00July 29th, 2022|The New York Times|
Teva Reaches Tentative $4.25 Billion Settlement Over Opioidsnews2022-07-26T22:26:32+00:00July 26th, 2022|The New York Times|
Teva Pharmaceuticals Found Liable in Landmark Opioid Trialnews2021-12-30T23:06:33+00:00December 30th, 2021|The New York Times|
Opioid Makers Win Major Victory in California Trialnews2021-11-02T16:51:06+00:00November 2nd, 2021|The New York Times|
Drug Companies to Pay N.Y. More Than $1 Billion to Settle Opioid Lawsuitnews2021-07-20T20:40:18+00:00July 20th, 2021|The New York Times|
